 Lisa Pomrenke on Aug 17th, 2018 // No Comments
Deutsche Bank set a â‚¬62.00 ($70.45) target price on Compugroup Medical (ETR:COP) in a report published on Tuesday morning. The brokerage currently has a buy rating on the stock.
Other equities analysts have also recently issued research reports about the company. Commerzbank set a â‚¬60.00 ($68.18) price target on Compugroup Medical and gave the company a buy rating in a report on Thursday, May 3rd. Warburg Research set a â‚¬53.00 ($60.23) price target on Compugroup Medical and gave the company a buy rating in a report on Wednesday, April 25th. HSBC set a â‚¬57.00 ($64.77) price target on Compugroup Medical and gave the company a buy rating in a report on Friday, June 1st. Baader Bank set a â‚¬46.00 ($52.27) price target on Compugroup Medical and gave the company a neutral rating in a report on Monday, July 30th. Finally, Berenberg Bank set a â‚¬49.00 ($55.68) price target on Compugroup Medical and gave the company a neutral rating in a report on Monday, July 16th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. The stock currently has an average rating of Buy and a consensus price target of â‚¬54.50 ($61.93). Get Compugroup Medical alerts:
Compugroup Medical stock opened at â‚¬48.72 ($55.36) on Tuesday. Compugroup Medical has a 12 month low of â‚¬40.10 ($45.57) and a 12 month high of â‚¬60.30 ($68.52). About Compugroup Medical
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks